CGAS and fatty liver disease: For example, nuclear cGAS has been reported to suppress DNA damage repair by directly binding and inhibiting PARP1[27] and to regulate genome stability by decelerating replication forks.[28] Nonetheless, whether and how cGAS exerts additional innate immunity‐independent function in fatty liver disease remains unclear.